NPI: 1407233240 · TUSTIN, CA 92780 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/30/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/30/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,331 | $135K |
| 2019 | 4,078 | $161K |
| 2020 | 5,936 | $315K |
| 2021 | 10,879 | $531K |
| 2022 | 18,902 | $1.05M |
| 2023 | 8,472 | $1.13M |
| 2024 | 2,555 | $627K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,973 | 2,049 | $3.53M |
| A4657 | Syringe, with or without needle, each | 511 | 443 | $227K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 956 | 479 | $100K |
| 0250 | 726 | 183 | $84K | |
| 82728 | 222 | 217 | $4K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,348 | 994 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 82 | 81 | $2K |
| 90670 | 14 | 14 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | 3,319 | 837 | $1K |
| 82108 | 23 | 23 | $812.11 | |
| 90674 | 21 | 17 | $536.00 | |
| 83970 | 285 | 270 | $12.94 | |
| 83550 | 245 | 239 | $2.65 | |
| 83540 | 265 | 259 | $2.05 | |
| 85041 | 385 | 363 | $0.39 | |
| 85048 | 385 | 363 | $0.33 | |
| 0634 | 252 | 12 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,967 | 438 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 120 | 55 | $0.00 |
| 0821 | 54 | 51 | $0.00 |